Antimicrobial agentsa
|
Asymptomatic carriers (n = 52)
|
CAP carriers (n = 31)
|
---|
CC271, n (%)
|
Others, n (%)
|
P valuesb
|
CC271, n (%)
|
Others, n (%)
|
P valuesb
|
---|
ERY
|
6 (100)
|
46 (100)
|
–
|
15 (100)
|
6 (100)
|
–
|
CLI
|
6 (100)
|
46 (100)
|
–
|
15 (100)
|
6 (100)
|
–
|
SXT
|
6 (100)
|
38 (82.6)
|
0.573
|
15 (100)
|
6 (100)
|
0.043
|
TET
|
6 (100)
|
34 (73.9)
|
0.316
|
15 (100)
|
6 (100)
|
1.000
|
CXM
|
6 (100)
|
19 (41.3)
|
0.002
|
14 (93.3)
|
6 (100)
|
0.009
|
CHL
|
0 (0.0)
|
5 (10.9)
|
1.000
|
2 (13.3)
|
0 (0.0)
|
0.600
|
CEF
|
4 (66.7)
|
1 (2.2)
|
0.000
|
8 (53.3)
|
4 (66.7)
|
0.015
|
PEN
|
6 (100)
|
31 (67.4)
|
0.165
|
14 (93.3)
|
6 (100)
|
0.015
|
CRO (Non-meningitis)
|
0 (0.0)
|
0 (0.0)
|
–
|
0 (0.0)
|
0 (0.0)
|
0.484
|
MER
|
3 (50.0)
|
2 (4.4)
|
0.043
|
4 (26.7)
|
3 (50.0)
|
0.008
|
CFP (Non-meningitis)
|
4 (66.7)
|
0 (0.0)
|
0.037
|
6 (40.0)
|
4 (66.7)
|
0.000
|
MOX
|
0 (0.0)
|
0 (0.0)
|
–
|
0 (0.0)
|
0 (0.0)
|
–
|
LEV
|
0 (0.0)
|
1 (2.2)
|
1.000
|
0 (0.0)
|
0 (0.0)
|
–
|
VAN
|
0 (0.0)
|
0 (0.0)
|
–
|
2 (13.3)
|
0 (0.0)
|
0.226
|
RIF
|
0 (0.0)
|
1 (2.2)
|
1.000
|
3 (0.2)
|
0 (0.0)
|
0.101
|
AMPC/CVA (Non-meningitis)
|
1 (16.7)
|
0 (0.0)
|
0.115
|
1 (6.7)
|
1 (16.7)
|
1.000
|
LIN
|
1 (16.7)
|
1 (2.2)
|
0.219
|
2 (13.3)
|
1 (16.7)
|
0.226
|
- aERY erythromycin, CLI clindamycin, SXT trimethoprim-sulfamethoxazole, TET tetracycline, CXM cefuroxime, CHL chloramphenicol, CEF cefotaxime, PEN penicillin, CRO ceftriaxone, MER meropenem, CFP cefepime, MOX moxifloxacin, LEV levofloxacin, VAN vancomycin, RIF rifampicin, AMPC/CVA amoxicillin/clavulanic acid, LIN linezolid
- bFisher’s Exact Test was used